List of Tables
Table 1. Global Computational Drug Discovery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Structure-based Drug Design (SBDD)
Table 3. Key Players of Ligand-based Drug Design (LBDD)
Table 4. Key Players of Sequence-based Approaches
Table 5. Global Computational Drug Discovery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Computational Drug Discovery Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Computational Drug Discovery Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Computational Drug Discovery Revenue Market Share by Region (2017-2022)
Table 9. Global Computational Drug Discovery Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Computational Drug Discovery Market Share by Players (2017-2022)
Table 11. Global Top Computational Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Drug Discovery as of 2021)
Table 12. Ranking of Global Top Computational Drug Discovery Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Computational Drug Discovery Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Computational Drug Discovery Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Computational Drug Discovery Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Computational Drug Discovery Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Computational Drug Discovery Revenue Market Share by Type (2017-2022)
Table 20. Global Computational Drug Discovery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Computational Drug Discovery Revenue Market Share by Type (2023-2028)
Table 22. Global Computational Drug Discovery Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Computational Drug Discovery Revenue Market Share by Application (2017-2022)
Table 24. Global Computational Drug Discovery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Computational Drug Discovery Revenue Market Share by Application (2023-2028)
Table 26. North America Computational Drug Discovery Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Computational Drug Discovery Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Computational Drug Discovery Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Computational Drug Discovery Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Computational Drug Discovery Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Computational Drug Discovery Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Computational Drug Discovery Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Computational Drug Discovery Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Computational Drug Discovery Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Computational Drug Discovery Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Computational Drug Discovery Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Computational Drug Discovery Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Computational Drug Discovery Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Computational Drug Discovery Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Computational Drug Discovery Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Computational Drug Discovery Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Computational Drug Discovery Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Computational Drug Discovery Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Computational Drug Discovery Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Computational Drug Discovery Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Computational Drug Discovery Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Computational Drug Discovery Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Computational Drug Discovery Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Computational Drug Discovery Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Computational Drug Discovery Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Computational Drug Discovery Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Computational Drug Discovery Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Computational Drug Discovery Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Computational Drug Discovery Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Computational Drug Discovery Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Computational Drug Discovery Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Computational Drug Discovery Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Computational Drug Discovery Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Computational Drug Discovery Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Computational Drug Discovery Revenue by Country (2023-2028) & (US$ Million)
Table 61. AMRI Company Details
Table 62. AMRI Business Overview
Table 63. AMRI Computational Drug Discovery Product and Services
Table 64. AMRI Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 65. AMRI Computational Drug Discovery SWOT Analysis
Table 66. AMRI Recent Developments
Table 67. Charles River Company Details
Table 68. Charles River Business Overview
Table 69. Charles River Computational Drug Discovery Product and Services
Table 70. Charles River Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 71. Charles River Computational Drug Discovery SWOT Analysis
Table 72. Charles River Recent Developments
Table 73. Schrödinger Company Details
Table 74. Schrödinger Business Overview
Table 75. Schrödinger Computational Drug Discovery Product and Services
Table 76. Schrödinger Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 77. Schrödinger Computational Drug Discovery SWOT Analysis
Table 78. Schrödinger Recent Developments
Table 79. Evotec Company Details
Table 80. Evotec Business Overview
Table 81. Evotec Computational Drug Discovery Product and Services
Table 82. Evotec Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 83. Evotec Computational Drug Discovery SWOT Analysis
Table 84. Evotec Recent Developments
Table 85. Bayers Company Details
Table 86. Bayers Business Overview
Table 87. Bayers Computational Drug Discovery Product and Services
Table 88. Bayers Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 89. Bayers Computational Drug Discovery SWOT Analysis
Table 90. Bayers Recent Developments
Table 91. GVK Biosciences Company Details
Table 92. GVK Biosciences Business Overview
Table 93. GVK Biosciences Computational Drug Discovery Product and Services
Table 94. GVK Biosciences Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 95. GVK Biosciences Computational Drug Discovery SWOT Analysis
Table 96. GVK Biosciences Recent Developments
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Computational Drug Discovery Product and Services
Table 100. AstraZeneca Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 101. AstraZeneca Computational Drug Discovery SWOT Analysis
Table 102. AstraZeneca Recent Developments
Table 103. BioDuro Company Details
Table 104. BioDuro Business Overview
Table 105. BioDuro Computational Drug Discovery Product and Services
Table 106. BioDuro Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 107. BioDuro Computational Drug Discovery SWOT Analysis
Table 108. BioDuro Recent Developments
Table 109. BOC Sciences Company Details
Table 110. BOC Sciences Business Overview
Table 111. BOC Sciences Computational Drug Discovery Product and Services
Table 112. BOC Sciences Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 113. BOC Sciences Computational Drug Discovery SWOT Analysis
Table 114. BOC Sciences Recent Developments
Table 115. Aris Pharmaceuticals Company Details
Table 116. Aris Pharmaceuticals Business Overview
Table 117. Aris Pharmaceuticals Computational Drug Discovery Product and Services
Table 118. Aris Pharmaceuticals Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 119. Aris Pharmaceuticals Computational Drug Discovery SWOT Analysis
Table 120. Aris Pharmaceuticals Recent Developments
Table 121. ChemDiv Company Details
Table 122. ChemDiv Business Overview
Table 123. ChemDiv Computational Drug Discovery Product and Services
Table 124. ChemDiv Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 125. ChemDiv Recent Developments
Table 126. RTI International Company Details
Table 127. RTI International Business Overview
Table 128. RTI International Computational Drug Discovery Product and Services
Table 129. RTI International Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 130. RTI International Recent Developments
Table 131. XRQTC Company Details
Table 132. XRQTC Business Overview
Table 133. XRQTC Computational Drug Discovery Product and Services
Table 134. XRQTC Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 135. XRQTC Recent Developments
Table 136. Pharmaron Company Details
Table 137. Pharmaron Business Overview
Table 138. Pharmaron Computational Drug Discovery Product and Services
Table 139. Pharmaron Computational Drug Discovery Revenue in Computational Drug Discovery Business (2017-2022) & (US$ Million)
Table 140. Pharmaron Recent Developments
Table 141. Computational Drug Discovery Market Trends
Table 142. Computational Drug Discovery Market Drivers
Table 143. Computational Drug Discovery Market Challenges
Table 144. Computational Drug Discovery Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Computational Drug Discovery Sales Market Share by Type: 2021 VS 2028
Figure 2. Structure-based Drug Design (SBDD) Features
Figure 3. Ligand-based Drug Design (LBDD) Features
Figure 4. Sequence-based Approaches Features
Figure 5. Global Computational Drug Discovery Sales Market Share by Application: 2021 VS 2028
Figure 6. Oncological Disorders Case Studies
Figure 7. Neurological Disorders Case Studies
Figure 8. Immunological Disorders Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Computational Drug Discovery Report Years Considered
Figure 12. Global Computational Drug Discovery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Computational Drug Discovery Market Size 2017-2028 (US$ Million)
Figure 14. Global Computational Drug Discovery Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Computational Drug Discovery Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Computational Drug Discovery Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Computational Drug Discovery Market Share by Players in 2021
Figure 18. Global Top Computational Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Drug Discovery as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Computational Drug Discovery Revenue in 2021
Figure 20. North America Computational Drug Discovery Revenue Market Share by Company in 2021
Figure 21. North America Computational Drug Discovery Revenue Market Share by Type (2017-2028)
Figure 22. North America Computational Drug Discovery Revenue Market Share by Application (2017-2028)
Figure 23. North America Computational Drug Discovery Revenue Share by Country (2017-2028)
Figure 24. United States Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Computational Drug Discovery Revenue Market Share by Company in 2021
Figure 27. Europe Computational Drug Discovery Revenue Market Share by Type (2017-2028)
Figure 28. Europe Computational Drug Discovery Revenue Market Share by Application (2017-2028)
Figure 29. Europe Computational Drug Discovery Revenue Share by Country (2017-2028)
Figure 30. Germany Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 31. France Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Computational Drug Discovery Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Computational Drug Discovery Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Computational Drug Discovery Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific Computational Drug Discovery Revenue Share by Region (2017-2028)
Figure 39. China Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 42. India Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 44. China Taiwan Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Computational Drug Discovery Revenue Market Share by Company in 2021
Figure 49. Latin America Computational Drug Discovery Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Computational Drug Discovery Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Computational Drug Discovery Revenue Share by Country (2017-2028)
Figure 52. Mexico Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Computational Drug Discovery Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Computational Drug Discovery Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Computational Drug Discovery Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Computational Drug Discovery Revenue Share by Country (2017-2028)
Figure 59. Turkey Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Computational Drug Discovery Revenue (2017-2028) & (US$ Million)
Figure 62. AMRI Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 63. Charles River Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 64. Schrödinger Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 65. Evotec Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 66. Bayers Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 67. GVK Biosciences Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 68. AstraZeneca Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 69. BioDuro Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 70. BOC Sciences Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 71. Aris Pharmaceuticals Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 72. ChemDiv Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 73. RTI International Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 74. XRQTC Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 75. Pharmaron Revenue Growth Rate in Computational Drug Discovery Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
